Release of leukotriene B4 from human neutrophils measured by specific radioimmunoassay.
D015772:4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D000001:Calcimycin / Q000494:pharmacology; D003571:Cytochalasin B / Q000494:pharmacology; D015232:Dinoprostone; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D007700:Kinetics; D007975:Leukotriene B4 / Q000097:blood* / Q000378:metabolism; D009239:N-Formylmethionine / Q000031:analogs & derivatives / Q000494:pharmacology; D009240:N-Formylmethionine Leucyl-Phenylalanine; D009504:Neutrophils / Q000187:drug effects / Q000378:metabolism*; D009842:Oligopeptides / Q000494:pharmacology; D011458:Prostaglandins E / Q000097:blood; D011720:Pyrazoles / Q000494:pharmacology; D011863:Radioimmunoassay / Q000379:methods; D013929:Thromboxane B2 / Q000097:blood
D000893:Anti-Inflammatory Agents; D009842:Oligopeptides; D011458:Prostaglandins E; D011720:Pyrazoles; D007975:Leukotriene B4; D000001:Calcimycin; D003571:Cytochalasin B; D009239:N-Formylmethionine; D013929:Thromboxane B2; D009240:N-Formylmethionine Leucyl-Phenylalanine; D015772:4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; D015232:Dinoprostone; D007213:Indomethacin